Nanoparticles in Biotechnology and Pharmaceuticals Market Report

Nanoparticles in Biotechnology and Pharmaceuticals Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Dec 23, 2019
  • PAGES：157
  • REPORT CODE：GMM409037
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Nanoparticles in Biotechnology and Pharmaceuticals market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 14.6% during the forecast period.

    This report presents the market size and development trends by detailing the Nanoparticles in Biotechnology and Pharmaceuticals market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Nanoparticles in Biotechnology and Pharmaceuticals market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Nanoparticles in Biotechnology and Pharmaceuticals industry and will help you to build a panoramic view of the industrial development.

    Nanoparticles in Biotechnology and Pharmaceuticals Market, By Type:

    • Fullerenes

    • Liquid Crystals

    • Liposomes

    • Nanoshells

    • Quantum dots

    • Superparamagnetic nanoparticles

    Nanoparticles in Biotechnology and Pharmaceuticals Market, By Application:

    • Biotechnology

    • Pharmaceutical

    Some of the leading players are as follows:

    • Pacira Pharmaceuticals

    • Biogen

    • Amgen

    • Celgene

    • Gilead

    • Roche

    • Leadiant Biosciences

    • Merck

    • GE Healthcare

    • Novartis

    • nanoComposix

    • Ipsen

    • Pfizer

    • AMAG Pharmaceuticals

    • Bausch & Lomb

    • Shire

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Nanoparticles in Biotechnology and Pharmaceuticals Market: Technology Type Analysis

    • 4.1 Nanoparticles in Biotechnology and Pharmaceuticals Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Nanoparticles in Biotechnology and Pharmaceuticals Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Fullerenes

      • 4.3.2 Liquid Crystals

      • 4.3.3 Liposomes

      • 4.3.4 Nanoshells

      • 4.3.5 Quantum dots

      • 4.3.6 Superparamagnetic nanoparticles

    5 Nanoparticles in Biotechnology and Pharmaceuticals Market: Product Analysis

    • 5.1 Nanoparticles in Biotechnology and Pharmaceuticals Product Market Share Analysis, 2018 & 2026

    • 5.2 Nanoparticles in Biotechnology and Pharmaceuticals Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Nanoparticles in Biotechnology and Pharmaceuticals Market: Application Analysis

    • 6.1 Nanoparticles in Biotechnology and Pharmaceuticals Application Market Share Analysis, 2018 & 2026

    • 6.2 Nanoparticles in Biotechnology and Pharmaceuticals Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Biotechnology

      • 6.3.2 Pharmaceutical

    7 Nanoparticles in Biotechnology and Pharmaceuticals Market: Regional Analysis

    • 7.1 Nanoparticles in Biotechnology and Pharmaceuticals Regional Market Share Analysis, 2018 & 2026

    • 7.2 Nanoparticles in Biotechnology and Pharmaceuticals Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Pacira Pharmaceuticals

      • 9.1.1 Pacira Pharmaceuticals Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Biogen

      • 9.2.1 Biogen Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Amgen

      • 9.3.1 Amgen Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Celgene

      • 9.4.1 Celgene Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Gilead

      • 9.5.1 Gilead Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Roche

      • 9.6.1 Roche Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Leadiant Biosciences

      • 9.7.1 Leadiant Biosciences Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Merck

      • 9.8.1 Merck Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 GE Healthcare

      • 9.9.1 GE Healthcare Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 Novartis

      • 9.10.1 Novartis Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

    • 9.11 nanoComposix

      • 9.11.1 nanoComposix Company overview

      • 9.11.2 Financial performance

      • 9.11.3 Product benchmarking

      • 9.11.4 Strategic initiatives

      • 9.11.5 SWOT analysis

    • 9.12 Ipsen

      • 9.12.1 Ipsen Company overview

      • 9.12.2 Financial performance

      • 9.12.3 Product benchmarking

      • 9.12.4 Strategic initiatives

      • 9.12.5 SWOT analysis

    • 9.13 Pfizer

      • 9.13.1 Pfizer Company overview

      • 9.13.2 Financial performance

      • 9.13.3 Product benchmarking

      • 9.13.4 Strategic initiatives

      • 9.13.5 SWOT analysis

    • 9.14 AMAG Pharmaceuticals

      • 9.14.1 AMAG Pharmaceuticals Company overview

      • 9.14.2 Financial performance

      • 9.14.3 Product benchmarking

      • 9.14.4 Strategic initiatives

      • 9.14.5 SWOT analysis

    • 9.15 Bausch & Lomb

      • 9.15.1 Bausch & Lomb Company overview

      • 9.15.2 Financial performance

      • 9.15.3 Product benchmarking

      • 9.15.4 Strategic initiatives

      • 9.15.5 SWOT analysis

    • 9.16 Shire

      • 9.16.1 Shire Company overview

      • 9.16.2 Financial performance

      • 9.16.3 Product benchmarking

      • 9.16.4 Strategic initiatives

      • 9.16.5 SWOT analysis

     

    The List of Tables and Figures (Totals 109 Figures and 154 Tables)

    • Figure Fullerenes Nanoparticles in Biotechnology and Pharmaceuticals market, 2015 - 2026 (USD Million)

    • Figure Liquid Crystals Nanoparticles in Biotechnology and Pharmaceuticals market, 2015 - 2026 (USD Million)

    • Figure Liposomes Nanoparticles in Biotechnology and Pharmaceuticals market, 2015 - 2026 (USD Million)

    • Figure Nanoshells Nanoparticles in Biotechnology and Pharmaceuticals market, 2015 - 2026 (USD Million)

    • Figure Quantum dots Nanoparticles in Biotechnology and Pharmaceuticals market, 2015 - 2026 (USD Million)

    • Figure Superparamagnetic nanoparticles Nanoparticles in Biotechnology and Pharmaceuticals market, 2015 - 2026 (USD Million)

    • Figure Biotechnology market, 2015 - 2026 (USD Million)

    • Figure Pharmaceutical market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Nanoparticles in Biotechnology and Pharmaceuticals market, by country, 2015 - 2026 (USD Million)

    • Table North America Nanoparticles in Biotechnology and Pharmaceuticals market, by type, 2015 - 2026 (USD Million)

    • Table North America Nanoparticles in Biotechnology and Pharmaceuticals market, by product, 2015 - 2026 (USD Million)

    • Table North America Nanoparticles in Biotechnology and Pharmaceuticals market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Nanoparticles in Biotechnology and Pharmaceuticals market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Nanoparticles in Biotechnology and Pharmaceuticals market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Nanoparticles in Biotechnology and Pharmaceuticals market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Nanoparticles in Biotechnology and Pharmaceuticals market, by type, 2015 - 2026 (USD Million)

    • Table Canada Nanoparticles in Biotechnology and Pharmaceuticals market, by product, 2015 - 2026 (USD Million)

    • Table Canada Nanoparticles in Biotechnology and Pharmaceuticals market, by application, 2015 - 2026 (USD Million)

    • Table Europe Nanoparticles in Biotechnology and Pharmaceuticals market, by country, 2015 - 2026 (USD Million)

    • Table Europe Nanoparticles in Biotechnology and Pharmaceuticals market, by type, 2015 - 2026 (USD Million)

    • Table Europe Nanoparticles in Biotechnology and Pharmaceuticals market, by product, 2015 - 2026 (USD Million)

    • Table Europe Nanoparticles in Biotechnology and Pharmaceuticals market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Nanoparticles in Biotechnology and Pharmaceuticals market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Nanoparticles in Biotechnology and Pharmaceuticals market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Nanoparticles in Biotechnology and Pharmaceuticals market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Nanoparticles in Biotechnology and Pharmaceuticals market, by type, 2015 - 2026 (USD Million)

    • Table Germany Nanoparticles in Biotechnology and Pharmaceuticals market, by product, 2015 - 2026 (USD Million)

    • Table Germany Nanoparticles in Biotechnology and Pharmaceuticals market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Nanoparticles in Biotechnology and Pharmaceuticals market, by type, 2015 - 2026 (USD Million)

    • Table France Nanoparticles in Biotechnology and Pharmaceuticals market, by product, 2015 - 2026 (USD Million)

    • Table France Nanoparticles in Biotechnology and Pharmaceuticals market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Nanoparticles in Biotechnology and Pharmaceuticals market, by type, 2015 - 2026 (USD Million)

    • Table Italy Nanoparticles in Biotechnology and Pharmaceuticals market, by product, 2015 - 2026 (USD Million)

    • Table Italy Nanoparticles in Biotechnology and Pharmaceuticals market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Nanoparticles in Biotechnology and Pharmaceuticals market, by type, 2015 - 2026 (USD Million)

    • Table Spain Nanoparticles in Biotechnology and Pharmaceuticals market, by product, 2015 - 2026 (USD Million)

    • Table Spain Nanoparticles in Biotechnology and Pharmaceuticals market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Nanoparticles in Biotechnology and Pharmaceuticals market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Nanoparticles in Biotechnology and Pharmaceuticals market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Nanoparticles in Biotechnology and Pharmaceuticals market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Nanoparticles in Biotechnology and Pharmaceuticals market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Nanoparticles in Biotechnology and Pharmaceuticals market, by type, 2015 - 2026 (USD Million)

    • Table China Nanoparticles in Biotechnology and Pharmaceuticals market, by product, 2015 - 2026 (USD Million)

    • Table China Nanoparticles in Biotechnology and Pharmaceuticals market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Nanoparticles in Biotechnology and Pharmaceuticals market, by type, 2015 - 2026 (USD Million)

    • Table Japan Nanoparticles in Biotechnology and Pharmaceuticals market, by product, 2015 - 2026 (USD Million)

    • Table Japan Nanoparticles in Biotechnology and Pharmaceuticals market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Nanoparticles in Biotechnology and Pharmaceuticals market, by type, 2015 - 2026 (USD Million)

    • Table India Nanoparticles in Biotechnology and Pharmaceuticals market, by product, 2015 - 2026 (USD Million)

    • Table India Nanoparticles in Biotechnology and Pharmaceuticals market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Nanoparticles in Biotechnology and Pharmaceuticals market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Nanoparticles in Biotechnology and Pharmaceuticals market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Nanoparticles in Biotechnology and Pharmaceuticals market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Nanoparticles in Biotechnology and Pharmaceuticals market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Nanoparticles in Biotechnology and Pharmaceuticals market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Nanoparticles in Biotechnology and Pharmaceuticals market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Nanoparticles in Biotechnology and Pharmaceuticals market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Nanoparticles in Biotechnology and Pharmaceuticals market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Nanoparticles in Biotechnology and Pharmaceuticals market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Nanoparticles in Biotechnology and Pharmaceuticals market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Nanoparticles in Biotechnology and Pharmaceuticals market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Nanoparticles in Biotechnology and Pharmaceuticals market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Nanoparticles in Biotechnology and Pharmaceuticals market, by application, 2015 - 2026 (USD Million)

    • Table MEA Nanoparticles in Biotechnology and Pharmaceuticals market, by country, 2015 - 2026 (USD Million)

    • Table MEA Nanoparticles in Biotechnology and Pharmaceuticals market, by type, 2015 - 2026 (USD Million)

    • Table MEA Nanoparticles in Biotechnology and Pharmaceuticals market, by product, 2015 - 2026 (USD Million)

    • Table MEA Nanoparticles in Biotechnology and Pharmaceuticals market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Nanoparticles in Biotechnology and Pharmaceuticals market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Nanoparticles in Biotechnology and Pharmaceuticals market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Nanoparticles in Biotechnology and Pharmaceuticals market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Nanoparticles in Biotechnology and Pharmaceuticals market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Nanoparticles in Biotechnology and Pharmaceuticals market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Nanoparticles in Biotechnology and Pharmaceuticals market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Pacira Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Biogen Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Amgen Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Celgene Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Gilead Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Roche Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Leadiant Biosciences Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Merck Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table GE Healthcare Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Novartis Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table nanoComposix Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Ipsen Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table AMAG Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Bausch & Lomb Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Shire Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US